Current values at or above the 220 nA threshold differentiate between samples with a low PSA concentration and those with a normal prostate or with BPH, enabling further investigation of current values above the 220 nA threshold, which can improve the detection rate of PCa, as PSA is an unreliable screening test for PCa. This evidence concerns the gene KLK3 and benign prostatic hyperplasia.